Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/15/22
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 04/19/23
End: 10/31/27
Due: 10/31/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) | NCT05519449 | Janux Therapeutics | user2@example.com | None | 2022-09-15 | 2028-12-31 | 2029-12-31 | - | - | 2025-07-14 |
| Study of JANX008 in Subjects with Advanced or Metastatic Solid Tumor Malignancies | NCT05783622 | Janux Therapeutics | user2@example.com | None | 2023-04-19 | 2027-10-31 | 2028-10-31 | - | - | 2025-07-14 |